Gilead Sciences: Don’t You Forget About Me
August 22, 2014 at 14:14 PM EDT
With all the attention paid to Gilead Sciences’ (GILD) Hepatitis C treatment, Sovaldi, RBC’s Michael Yee and team remind investors not to forget about its HIV drug: AP Investors have been highly focused on Hep C but we remind investors that Gilead’s HIV franchise is also a $10B+ giant and we think the tail is [...]
